Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 24, 2021 at 09:52 am
Share
Qingdao Haier Biomedical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 927.954 million compared to CNY 594.633 million a year ago. Operating income was CNY 642.252 million compared to CNY 175.553 million a year ago. Net income was CNY 573.077 million compared to CNY 154.861 million a year ago. Basic earnings per share from continuing operations was CNY 1.81 compared to CNY 0.49 a year ago.
Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.
QINGDAO HAIER BIOMEDICAL CO.,LTD 
